241 related articles for article (PubMed ID: 19095365)
1. Chronic prostatitis/chronic pelvic pain syndrome in males may be an autoimmune disease, potentially responsive to corticosteroid therapy.
Tomaskovic I; Ruzic B; Trnski D; Kraus O
Med Hypotheses; 2009 Mar; 72(3):261-2. PubMed ID: 19095365
[TBL] [Abstract][Full Text] [Related]
2. α-blockers, antibiotics and anti-inflammatories have a role in the management of chronic prostatitis/chronic pelvic pain syndrome.
Thakkinstian A; Attia J; Anothaisintawee T; Nickel JC
BJU Int; 2012 Oct; 110(7):1014-22. PubMed ID: 22471591
[TBL] [Abstract][Full Text] [Related]
3. Frequent ejaculation associated free radical and lactic acid accumulation cause noninfectious inflammation and muscle dysfunction: a potential mechanism for symptoms in Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
Peng H; Chen Q; Tan Y
Med Hypotheses; 2009 Sep; 73(3):372-3. PubMed ID: 19435656
[TBL] [Abstract][Full Text] [Related]
4. Role of alpha1-blockers in chronic prostatitis syndromes.
Nickel JC
BJU Int; 2008 Mar; 101 Suppl 3():11-6. PubMed ID: 18307680
[TBL] [Abstract][Full Text] [Related]
5. Pharmacotherapy strategies in chronic prostatitis/chronic pelvic pain syndrome management.
Murphy AB; Nadler RB
Expert Opin Pharmacother; 2010 Jun; 11(8):1255-61. PubMed ID: 20429665
[TBL] [Abstract][Full Text] [Related]
6. Contemporary Management of Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
Magistro G; Wagenlehner FM; Grabe M; Weidner W; Stief CG; Nickel JC
Eur Urol; 2016 Feb; 69(2):286-97. PubMed ID: 26411805
[TBL] [Abstract][Full Text] [Related]
7. A nanoparticle-coupled T2 peptide induces immune tolerance and ameliorates chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) in mice model.
Cao Y; Cheng Y; Ihsan AU; Khan FU; Xie D; Cui X; Wang W; Zhou X
Fundam Clin Pharmacol; 2019 Jun; 33(3):267-276. PubMed ID: 30471234
[TBL] [Abstract][Full Text] [Related]
8. A prospective, randomized, double-blind trial to evaluate the role of a short reducing course of oral corticosteroid therapy in the treatment of chronic prostatitis/chronic pelvic pain syndrome.
Bates SM; Hill VA; Anderson JB; Chapple CR; Spence R; Ryan C; Talbot MD
BJU Int; 2007 Feb; 99(2):355-9. PubMed ID: 17313424
[TBL] [Abstract][Full Text] [Related]
9. Fluoxetine ameliorates symptoms of refractory chronic prostatitis/chronic pelvic pain syndrome.
Xia D; Wang P; Chen J; Wang S; Jiang H
Chin Med J (Engl); 2011 Jul; 124(14):2158-61. PubMed ID: 21933619
[TBL] [Abstract][Full Text] [Related]
10. Acute bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: andrological implications.
Weidner W; Wagenlehner FM; Marconi M; Pilatz A; Pantke KH; Diemer T
Andrologia; 2008 Apr; 40(2):105-12. PubMed ID: 18336460
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms in prostatitis/chronic pelvic pain syndrome.
Pontari MA; Ruggieri MR
J Urol; 2004 Sep; 172(3):839-45. PubMed ID: 15310980
[TBL] [Abstract][Full Text] [Related]
12. TRPV1 in experimental autoimmune prostatitis.
Roman K; Hall C; Schaeffer AJ; Thumbikat P
Prostate; 2020 Jan; 80(1):28-37. PubMed ID: 31573117
[TBL] [Abstract][Full Text] [Related]
13. Cytokine polymorphisms in men with chronic prostatitis/chronic pelvic pain syndrome: association with diagnosis and treatment response.
Shoskes DA; Albakri Q; Thomas K; Cook D
J Urol; 2002 Jul; 168(1):331-5. PubMed ID: 12050565
[TBL] [Abstract][Full Text] [Related]
14. The effect of alpha-adrenergic antagonists in chronic prostatitis/chronic pelvic pain syndrome: a meta-analysis of randomized controlled trials.
Yang G; Wei Q; Li H; Yang Y; Zhang S; Dong Q
J Androl; 2006; 27(6):847-52. PubMed ID: 16870951
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune prostatitis: evidence of T cell reactivity with normal prostatic proteins.
Alexander RB; Brady F; Ponniah S
Urology; 1997 Dec; 50(6):893-9. PubMed ID: 9426720
[TBL] [Abstract][Full Text] [Related]
16. Prostate extract with aluminum hydroxide injection as a novel animal model for chronic prostatitis/chronic pelvic pain syndrome.
Qi X; Han L; Liu X; Zhi J; Zhao B; Chen D; Yu F; Zhou X
Urology; 2012 Dec; 80(6):1389.e9-15. PubMed ID: 23017785
[TBL] [Abstract][Full Text] [Related]
17. Management of chronic prostatitis/chronic pelvic pain syndrome: a systematic review and network meta-analysis.
Anothaisintawee T; Attia J; Nickel JC; Thammakraisorn S; Numthavaj P; McEvoy M; Thakkinstian A
JAMA; 2011 Jan; 305(1):78-86. PubMed ID: 21205969
[TBL] [Abstract][Full Text] [Related]
18. Treatment of chronic prostatitis/chronic pelvic pain syndrome category IIIA with Serenoa repens plus selenium and lycopene (Profluss) versus S. repens alone: an Italian randomized multicenter-controlled study.
Morgia G; Mucciardi G; Galì A; Madonia M; Marchese F; Di Benedetto A; Romano G; Bonvissuto G; Castelli T; Macchione L; Magno C
Urol Int; 2010; 84(4):400-6. PubMed ID: 20332612
[TBL] [Abstract][Full Text] [Related]
19. Evidences of the inflammasome pathway in chronic prostatitis and chronic pelvic pain syndrome in an animal model.
Chen CS; Chang PJ; Lin WY; Huang YC; Ho DR
Prostate; 2013 Mar; 73(4):391-7. PubMed ID: 22976935
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic approach to the management of the chronic prostatitis/chronic pelvic pain syndrome.
Nickel JC; Shoskes DA
BJU Int; 2010 Nov; 106(9):1252-63. PubMed ID: 20946349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
